Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl: a possible antioxidant strategy
- 30 November 1999
- journal article
- research article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 111 (2-3) , 211-221
- https://doi.org/10.1016/s0047-6374(99)00065-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Treatment with L-deprenyl prolongs life in elderly dogsLife Sciences, 1997
- Long term treatment with (−)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brainLife Sciences, 1996
- Upregulation of Antioxidant Enzyme Activities by DeprenylAnnals of the New York Academy of Sciences, 1996
- Ursodeoxycholic acid reduces the systemic toxicity of 1, 2-dichloro, 4-nitrobenzene by stimulating hepatic glutathione S-transferase in miceLife Sciences, 1994
- Chronic treatment of (-)deprenyl prolongs the life span of male fischer 344 rats. Further evidenceLife Sciences, 1993
- The optimal dosage of (−)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 ratsLife Sciences, 1993
- The ability of (−)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selectiveLife Sciences, 1992
- (−) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male ratsLife Sciences, 1991
- Maintenance on l-deprenyl prolongs life in aged male ratsLife Sciences, 1990
- Changes in the expression of superoxide dismutase and catalase as a function of age and dietary restrictionBiochemical and Biophysical Research Communications, 1989